List view / Grid view
The FDA is requiring that labels for opioid pain medicine and medicines to treat opioid use disorder recommend healthcare professionals discuss the availability of naloxone with patients to reduce overdoses.
The US FDA has announced a new dosage strength for Cassipa sublingual film for the maintenance treatment of opioid dependence...
Researchers have outlined a simple method to increase the number of injection-drug taking individuals with HIV to adhere to their medication...
NIH research confirms effective treatments for opioid use disorder are underutilised...
The FDA has approved the first generic versions of Suboxone sublingual film for the treatment of opioid dependence...
The FDA has announced its latest action to encourage and support the development of treatment options for people with opioid use disorder...
